Arama Sonuçları - Gisèle Bonne

Sonuçları Daraltın
  1. 1
    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies

    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies Yazar: Gisèle Bonne, Susana Quijano-Roy

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    “Laminopathies”: A wide spectrum of human diseases

    “Laminopathies”: A wide spectrum of human diseases Yazar: Howard J. Worman, Gisèle Bonne

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Emery-Dreifuss muscular dystrophy

    Emery-Dreifuss muscular dystrophy Yazar: A. Leclerc, Gisèle Bonne, Ketty Schwartz

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome)

    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome) Yazar: Gisèle Bonne, François Rivier, Dalil Hamroun

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome

    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome Yazar: Rachel Thompson, Gisèle Bonne, Paolo Missier, Hanns Lochmüller

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    The 2020 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2020 version of the gene table of neuromuscular disorders (nuclear genome) Yazar: Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    The 2021 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2021 version of the gene table of neuromuscular disorders (nuclear genome) Yazar: Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    The 2022 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2022 version of the gene table of neuromuscular disorders (nuclear genome) Yazar: Enzo Cohen, Gisèle Bonne, François Rivier, Dalil Hamroun

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    The 2023 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2023 version of the gene table of neuromuscular disorders (nuclear genome) Yazar: Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    The 2024 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2024 version of the gene table of neuromuscular disorders (nuclear genome) Yazar: Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development

    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development Yazar: Gisèle Bonne, Peter Seibel, Stefanie Possekel, C. Marsac, Bernhard Kadenbach

    Baskı/Yayın Bilgisi 1993
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene

    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene Yazar: Wei Wu, Antoine Muchir, Jian Shan, Gisèle Bonne, Howard J. Worman

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene

    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene Yazar: Wei Wu, Jian Shan, Gisèle Bonne, Howard J. Worman, Antoine Muchir

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy

    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy Yazar: Antoine Muchir, Paul Pavlidis, Gisèle Bonne, Yukiko Hayashi, Howard J. Worman

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins

    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins Yazar: Antoine Muchir, Jing Shan, Gisèle Bonne, Stephan E. Lehnart, Howard J. Worman

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    ColVI myopathies: where do we stand, where do we go?

    ColVI myopathies: where do we stand, where do we go? Yazar: Valérie Allamand, Laura Briñas, Pascale Richard, Tanya Stojkovic, Susana Quijano‐Roy, Gisèle Bonne

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Autophagic degradation of nuclear components in mammalian cells

    Autophagic degradation of nuclear components in mammalian cells Yazar: Young-Eun Park, Yukiko Hayashi, Gisèle Bonne, Takuro Arimura, S. Noguchi, Ikuya Nonaka, Ichizo Nishino

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations

    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations Yazar: Christophe Meune, Jop H. van Berlo, Frédéric Anselme, Gisèle Bonne, Yigal M. Pinto, Denis Duboc

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy

    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy Yazar: Anne-Claire Guénantin, Imen Jebeniani, Julia Leschik, Erwan Watrin, Gisèle Bonne, Nicolas Vignier, Michel Pucéat

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene

    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene Yazar: Antoine Muchir, Sarah A Reilly, W. Wu, Shinichi Iwata, Shunichi Homma, Gisèle Bonne, Howard J. Worman

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: